LEN
53
-3
VFC
15
-3
JPM
63
-3
HCA
48
-2
SHW
43
-6
MSFT
53
-4
PNW
59
6
GIS
60
-3
DUK
40
-5
HOG
26
-4
PAYX
42
-9
MCHP
58
-5
VMC
69
-3
DVN
37
-7
RSG
73
-4
MSI
49
-9
FSLR
54
-7
SYK
59
-3
DRI
56
-4
CNX
61
-8
LEN
53
-3
VFC
15
-3
JPM
63
-3
HCA
48
-2
SHW
43
-6
MSFT
53
-4
PNW
59
6
GIS
60
-3
DUK
40
-5
HOG
26
-4
PAYX
42
-9
MCHP
58
-5
VMC
69
-3
DVN
37
-7
RSG
73
-4
MSI
49
-9
FSLR
54
-7
SYK
59
-3
DRI
56
-4
CNX
61
-8
Financhill
Back

Pharming Group Quote, Financials, Valuation and Earnings

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.
Sell
32

PHAR
Pharming Group

Last Price:
9.80
Seasonality Move:
-0.25%

7 Day Trial

ALL ACCESS PASS

$ 7

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

Pharming Group Price Quote

$9.80
+0.03 (+0.31%)
(Updated: May 1, 2024 at 3:05 PM ET)

Pharming Group Key Stats

Sell
32
Pharming Group (PHAR) is a Sell
Day range:
$9.36 - $9.77
52-week range:
$9.27 - $16.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.89
P/B ratio:
3.01%
Volume:
1.2K
Avg. volume:
2.1K
1-year change:
-12.14%
Market cap:
$657.9M
Revenue:
$245.3M
EPS:
$-0.16

How Much Does Pharming Group Make?

Is Pharming Group Growing As A Company?

  • What Is Pharming Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.49%
  • What Is Pharming Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Pharming Group Stock Price Performance

  • Did Pharming Group Stock Go Up Last Month?
    Pharming Group share price went down by -9.87% last month
  • Did PHAR's Share Price Rise Over The Last Year?
    PHAR share price fell by -12.14% over the past 1 year

What Is Pharming Group 52-Week High & Low?

Pharming Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pharming Group?

  • How Much Debt Does Pharming Group Have?
    Total long term debt quarterly is $138.4M
  • How Much Cash Does Pharming Group Have?
    Cash and short term investments quarterly total is $213.4M
  • What Is Pharming Group’s Book Value Per Share?
    Book value per share is 3.26

Is Pharming Group Cash Flow Positive?

  • What Is PHAR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.3M
  • What Is Pharming Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1M
  • What Is Pharming Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$129.4M

Pharming Group Return On Invested Capital

  • Is Management Doing A Good Job?
    PHAR return on invested capital is -3.09%
  • What Is Pharming Group Return On Assets?
    ROA measures how assets are converting to revenues and is -2.42%
  • What Is PHAR Return On Equity?
    ROE is a measure of profitability and is -5.11%

Pharming Group Earnings Date & Stock Price

Pharming Group Competitors

Pharming Group Dividend Yield

Data Unavailable

Pharming Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -188.89%
Revenue: 48.69% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 38.50
Upside from Last Price: 294.06%

Major Shareholders

  • How many PHAR shares are owned by institutional investors?
    38.5M PHAR shares are owned by institutional investors
  • How many PHAR shares are owned by insiders?
    0 PHAR shares are owned by insiders